2,619
Views
2
CrossRef citations to date
0
Altmetric
Cardiovascular

Cost-utility and cost-benefit analysis of TAVR availability in the US severe symptomatic aortic stenosis patient population

, ORCID Icon, , , ORCID Icon, , & show all
Pages 1051-1060 | Received 02 Jun 2022, Accepted 09 Aug 2022, Published online: 25 Aug 2022